Vyvanse Shortage October 2025. Following its approval, fill rates for the. The national adhd medicine shortage, which has impacted access to generic versions of adderall, vyvanse, and concerta, was first announced back in october 2022.
Untreated adhd has significant negative consequences. Drug enforcement administration has increased the production limit for takeda pharmaceutical’s (4502.t) adhd drug vyvanse and its generic versions by about.